Delivery Order SPE2DB20D3103-SPE2DB24FN7V7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,076.56 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,299,676 units of 40mg Atorvastatin tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,049.14 firm-fixed-price contract is for the delivery of 4,560,272,823 units of 20 mg Atorvastatin tablets for medical use. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.38, is for the delivery of Atorvastatin 40 mg tablets (1,000 per bottle) and has a completion date of June 14, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Atorvastatin 40 mg tablets. The contract, valued at $1,640.20, has a completion date of November 22, 2022 and is a firm fixed-price, delivery order contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, with a ceiling value of $1,242.36. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. The ultimate completion date for this delivery order is September 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,925,635 units of Atorvastatin 80mg tablets, with a ceiling value of $1,730.51. The contract does not have a set-aside designation and is a firm fixed price, delivery order contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 90-count bottles of 20 milligram Atorvastatin tablets. The contract has a firm fixed price of $1,040.67 and a completion date of June 5, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $1,628.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,405,913 units of Atorvastatin 80 mg tablets, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price, and has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets, a cardiovascular medication, with a ceiling value of $3,304.55 and a performance period through April 2024. The contract is a delivery order, with a firm fixed price, and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.69 firm fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, is for the supply of 4,557,807 units of Atorvastatin 80 mg tablets. This contract supports the provision of critical pharmaceutical and medical supplies...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN7V7Delivery Order
This is a delivery order (SPE2DB24FN7V7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,571,363 units of Atorvastatin 40 mg tablets. The contract has a ceiling value of $1,140.61 and a completion date of May 13, 2024. It is a Firm Fixed Price contract with no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/10/24 |